Prescient Healthcare Group, a biopharmaceutical product and portfolio strategy firm, has named Dr Paul Harney as its new president, North America and its new director, it was reported yesterday.

Harney joins the company after spending more than 20 years offering guidance and support to the healthcare industry. Since completing his PhD in chemistry at Stony Brook University, Harney has held leadership roles at various firms including Deloitte Consulting, Quintiles and IQVIA. His areas of expertise include marketing, sales force optimisation, medical affairs, business development and supply chain.

Harney said, 'What Prescient has built really excites me and I see a huge potential to scale the US business. Our rich scientific, clinical and analytics heritage means we are perfectly positioned to help clients bring products with strong clinical benefits and attractive value propositions to market. I've inherited an impressive team and look forward to continuing to enhance the depth and breadth of services we bring to our clients.'